- MACK has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $12.5 million.
- MACK traded 144,819 shares today in the pre-market hours as of 7:55 AM, representing 10.7% of its average daily volume.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in MACK with the Ticky from Trade-Ideas. See the FREE profile for MACK NOW at Trade-Ideas More details on MACK: Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. Currently there are 4 analysts that rate Merrimack Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Merrimack Pharmaceuticals has been 1.4 million shares per day over the past 30 days. Merrimack has a market cap of $762.4 million and is part of the health care sector and drugs industry. The stock has a beta of 1.57 and a short float of 29.7% with 12.61 days to cover. Shares are up 34.5% year-to-date as of the close of trading on Monday.